MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells

Mingguang Lai1, Gang Du2, Ruiyue Shi1

  • 1Department of Gastroenterology, Shenzhen People's Hospital, Shenzhen, Guangdong 518020, P.R. China.

Insights

MicroRNA-34a (miR-34a) enhances colon cancer cell sensitivity to 5-fluorouracil (5-FU) chemotherapy. This involves regulating SIRT1/p53 pathway proteins, decreasing cell invasion and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNA-34a (miR-34a) is a tumor suppressor targeted by p53, but its role in colorectal cancer remains unclear.
  • Understanding miR-34a's mechanism is crucial for developing targeted colorectal cancer therapies.

Purpose of the Study:

  • To investigate the functional role of miR-34a in colorectal cancer cell invasion, migration, and apoptosis.
  • To elucidate the molecular mechanisms underlying miR-34a's effects, particularly in conjunction with 5-fluorouracil (5-FU) chemotherapy.

Main Methods:

  • Transient overexpression of miR-34a in SW480 colorectal cancer cells.
  • Assessment of cell migration and invasion assays.
  • Analysis of protein expression, including acetylated-p53 (ac-p53), p21, and sirtuin 1 (SIRT1).

Main Results:

  • Overexpression of miR-34a significantly reduced SW480 cell migration and invasion.
  • Combined miR-34a transfection and 5-FU treatment further inhibited cell migration and invasion.
  • These effects correlated with increased ac-p53 and p21, and decreased SIRT1 expression.

Conclusions:

  • miR-34a plays a critical role in suppressing colorectal cancer cell invasion and migration.
  • miR-34a enhances the efficacy of 5-FU chemotherapy in colon cancer cells.
  • The SIRT1/p53 pathway is a key mediator of miR-34a's tumor-suppressive functions and chemosensitization effects.